ReviewWorld journal of clinical cases2025
Intraocular pressure variation (ocular hypertension) in diabetes mellitus.
Review in World journal of clinical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research Progress of Diabetes-related Glaucoma: Mechanisms, Impacts and Management Strategies.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ocular hypertension (OHT), defined as increased intraocular pressure (IOP, > 21 mmHg) in eyes without optic disc changes or visual field changes, is a condition that puts an eye at higher risk of developing glaucomatous optic neuropathy and may be related to the translaminar pressure gradient, individual differences in IOP-related glaucoma susceptibility, effects of arterial blood pressure on the optic nerve head, and vasospastic factors. IOP remains the most common modifiable risk factor to protect eyes against the development of glaucoma. The association between OHT and diabetes mellitus (DM) is poorly understood, although ocular effects of both conditions are related to vascular compromise of retinal and optic nerve circulation. Increased IOP in diabetic patients is attributable to increased aqueous osmotic gradient and accumulation of extracellular matrix constituents in the trabecular meshwork. Autonomic dysfunction and genetic factors may also play a role. Apart from eyes without diabetic retinopathy (DR) changes, OHT can also be observed in eyes with DR, where it can develop with or without antecedent vitreoretinal intervention. For example, photocoagulation of the retina in earlier stages of proliferative DR protects against the development of OHT, whereas intraocular silicone oil injection promotes it. While IOP has been directly implicated as an independent risk factor for DR, the retinopathy in DM is also related to comorbidities, like hypertension and heart disease, that are also correlated with OHT. All these factors are discussed in a comprehensive review exploring the association of OHT and DM in detail.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.